1193116-74-3 Usage
Description
5-Bromo-2-(bromomethyl)pyrimidine, a pyrimidine derivative with the molecular formula C5H5Br2N2, is a chemical compound that features two bromine atoms and a bromomethyl group attached to the pyrimidine ring. 5-broMo-2-(broMoMethyl)pyriMidine is known for its versatility and importance in organic chemistry, particularly due to its potential applications in the synthesis of biologically active compounds.
Uses
Used in Organic Synthesis:
5-Bromo-2-(bromomethyl)pyrimidine is utilized as a key building block in the synthesis of various biologically active compounds, contributing to the development of new pharmaceuticals and agrochemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-bromo-2-(bromomethyl)pyrimidine is used as a precursor for the synthesis of drugs, taking advantage of its reactive bromine atoms and bromomethyl group to form diverse medicinal compounds with potential therapeutic effects.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 5-bromo-2-(bromomethyl)pyrimidine serves as a starting material for the creation of agrochemicals, such as pesticides and herbicides, leveraging its chemical properties to produce effective agents for agricultural applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1193116-74-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,3,1,1 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1193116-74:
(9*1)+(8*1)+(7*9)+(6*3)+(5*1)+(4*1)+(3*6)+(2*7)+(1*4)=143
143 % 10 = 3
So 1193116-74-3 is a valid CAS Registry Number.
1193116-74-3Relevant articles and documents
Heterocyclic kinase inhibitor
-
Paragraph 0269-0272, (2021/03/31)
The invention belongs to the technical field of medicines, and particularly relates to a heterocyclic DNA-PK kinase inhibitor compound shown as a general formula (I), a pharmaceutically acceptable salt and an isomer thereof, a pharmaceutical composition and preparation containing the compound, the pharmaceutically acceptable salt and the isomer thereof, a method for preparing the compound, the pharmaceutically acceptable salt and the isomer thereof, and application of the compound, the pharmaceutically acceptable salt and the isomer thereof.
BIARYLMETHYL HETEROCYCLES
-
Page/Page column 291, (2018/02/28)
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are biased agonists, or β-Arrestin agonists of the angiotensin II receptor, which may be used as medicaments.
SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
-
Page/Page column 263, (2019/01/05)
Disclosed are compounds of Formula (I): or a salt thereof, Formula (II) wherein R1 is: or; each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3a, R3b, L1, B, V, Y, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.
